PEPIN RONALD has filed 7 insider transactions across 1 company since June 2023.
Most recent transaction: a option exercise of 8333 shares of Celldex Therapeutics, Inc. ($CLDX) on December 15, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 15, 2025 | Celldex Therapeutics, Inc. | $CLDX | PEPIN RONALD | SR. VP & CBO | M | Common Stock | 8333 | $9.02 | 9,097.0000 | 66,420 | 1090.71% | 12.55% |
| Dec. 15, 2025 | Celldex Therapeutics, Inc. | $CLDX | PEPIN RONALD | SR. VP & CBO | M | Common Stock | 11000 | $2.78 | 20,097.0000 | 66,420 | 120.92% | 16.56% |
| Dec. 15, 2025 | Celldex Therapeutics, Inc. | $CLDX | PEPIN RONALD | SR. VP & CBO | M | Incentive Stock Option (right to buy) | 8333 | $0.00 | 5,000.0000 | 66,420 | 62.50% | 12.55% |
| Dec. 15, 2025 | Celldex Therapeutics, Inc. | $CLDX | PEPIN RONALD | SR. VP & CBO | M | Incentive Stock Option (right to buy) | 11000 | $0.00 | 0.0000 | 66,420 | 100.00% | 16.56% |
| June 5, 2025 | Celldex Therapeutics, Inc. | $CLDX | PEPIN RONALD | SR. VP & CBO | A | Incentive Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 66,383 | 9999.99% | 30.13% |
| June 13, 2024 | Celldex Therapeutics, Inc. | $CLDX | PEPIN RONALD | SR. VP & CBO | A | Incentive Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 58,871 | 9999.99% | 33.97% |
| June 15, 2023 | Celldex Therapeutics, Inc. | $CLDX | PEPIN RONALD | SR. VP & CBO | A | Incentive Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 47,214 | 9999.99% | 31.77% |